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Abstract 
Background: To evaluate the cardiac 
manifestations of aneurysmal subarachnoid 
haemorrhage (SAH) in term of its effects on 
haemodynamics and changes in electrocardiography, 
echocardiography and cardiac troponin I. 
 Methods: In this cross sectional study 96 patients, 
with a primary diagnosis of aneurysmal 
subarachnoid haemorrhage (SAH), were included . 
Cardiac abnormalities were defined as hypotension, 
pulmonary edema, ECG changes, echocardiographic 
wall motion abnormalities or reduction in ejection 
fraction below 50 percent and cardiac troponin I level 
above upper range of normal.  
Results: Mean age ±SD was 45.9±22.2. Males were 
57.6%. On presentation to the emergency department 
pulse was 77.2±13 beats/min, systolic blood pressure 
126.7±18 mmHg and diastolic blood pressure 
64.7±10.2 mmHg. Eleven patients (11.1%) developed 
pulmonary edema during ICU stay while 14.6% 
developed hypotension. ECG was abnormal in 
75.7%. Various abnormalities on ECG included 
symmetrical T wave inversion (35.5%), hyperacute T 
wave (13.1%), ST segment elevation (13.1%), ST 
segment depression (32.2%), long QT (34.3%), 
prominent U wave (14.1%), Sinus bradycardia 
(46.4%) and Sinus tachycardia (30.3%). 
Echocardiography showed wall motion 
abnormalities in 17.2%  and ejection fraction was less 
than 50 percent in 12.1%. Cardiac troponin I was 
elevated in 15.6%. 
Conclusion: Patients with aneurysmal 
subarachnoid haemorrhage frequently develop 
cardiac injury which manifests as hemodynamic 
derangement, electrocardiographic changes and 
regional or global left ventricular dysfunction on 
echocardiography. 
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manifestations  
 
Introduction 
    Subarachnoid haemorrhage (SAH) is a catastrophic 
neurological event which carries a high morbidity and 
mortality throughout the world. Considerable 
variation in the annual incidence of aneurysmal SAH 
exists in different regions of the world. It occurs 
primarily during young to mid adulthood in both 
sexes. Mortality rates vary widely. The most common 
cause of SAH is rupture of a congenital aneurysm in a 
blood vessel at the base of the brain. A less common 
source of hemorrhage is the rupture of an aneurysm of 
traumatic or infectious origin or rupture of an 
arteriovenous malformation. 1-2   
     In addition to the usual clinical signs and symptoms 
of SAH, which include abrupt onset of severe 
headache, nuchal rigidity, nausea, vomiting and 
alteration in consciousness, electrocardiographic 
(ECG) abnormalities often occur. These abnormalities 
include both morphological waveform changes in the 
12-lead ECG and arrhythmias. Although such cardiac 
manifestations can be associated with a wide variety of 
neurological events, including cerebrovascular 
accident, head injury, meningitis, and tumours, the 
highest prevalence and most pronounced changes 
occur after aneurysmal SAH. 3 
     ECG changes occur during the acute stage of SAH, 
with the most common abnormalities involving the ST 
segment, T wave, and QT interval. In most cases, these 
abnormalities are clinically inconsequential and are 
attributed to neurally mediated electrophysiological 
effects. Some SAH patients, however, show evidence 
of structural cardiac damage. Plasma levels of the 
creatine kinase myocardial isoenzyme (CK-MB) are 
mildly elevated in 20% to 50% of patients, and a 
characteristic form of myocardial pathology, 
contraction band necrosis, is commonly found at 
autopsy. A reversible form of neurogenic myocardial 
"stunning," presumably related to myocardial 
catecholamine toxicity and contraction band necrosis, 
may occur after SAH.4-6 
     Neurogenic ECG changes after SAH are usually 
regarded as asymptomatic. The potential impact of 
neurogenic cardiac injury on left ventricular 
hemodynamic performance after SAH has received 
little attention but may have important implications 
because approximately 30% of patients develop 
delayed cerebral ischemia related to vasospasm. 
Clinical studies in humans indicate that vasospasm is 
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associated with a loss of autoregulation and 
experimental studies have shown that cerebral blood 
flow (CBF) in ischemic areas can vary passively with 
changes in blood pressure and cardiac output.  
Accordingly, hypovolemia has been implicated as a 
risk factor for symptomatic vasospasm and 
augmentation of blood pressure and cardiac output 
can reverse ischemic deficits in affected patients. 7-10  
 
Patients and Methods 
     This descriptive study was conducted in the 
Department of Neurology, Lady Reading Hospital 
Peshawar from January 2008 to Dec 2011. Aneurysmal 
subarachnoid hemorrhage was diagnosed when a 
patient had sudden onset of severe headache and 
evidence of blood in brain ventricles on CT scan or, in 
case of negative CT scanning, by evidence of 
xanthochromia in the cerebrospinal fluid (performed 
12 hours after the ictus).  Aneurysm as source of 
bleeding was verified by MR cerebral angiography or 
CT angiography. Cardiac abnormalities were defined 
as hypotension, pulmonary edema, ECG changes, 
echocardiographic wall motion abnormalities or 
reduction in ejection fraction below 50 percent and 
cardiac troponin I level above upper range of normal.  
     Pulmonary edema was defined by the presence of 
characteristic diffuse infiltrates on chest radiography 
and reduced oxygenation requiring at least 40% 
supplemental oxygen. Hypotension was defined as a 
systolic blood pressure less than 100 mm Hg requiring 
treatment with intravenous pressors. Noncardiac 
causes of pulmonary infiltrates, hypoxemia, or 
hypotension were excluded.  
     Twelve Lead ECG was obtained and systematically 
analysed. Two–dimensional color–flow Doppler 
Transthoracic echocardiogram was performed. Left 
ventricular ejection fraction was measured using 
modified Simpson’s method. Two investigators 
(independent of each other and blinded from the 
clinical data of the patient) analyzed the 
echocardiographic images for the assessment of global 
and regional left ventricular function. Troponin I was 
measured on the first day of admission and was 
repeated on third day if the initial result was negative.  
      Patients having histories of hypertension, 
ischaemic heart disease, congestive heart failure, 
hypertrophic cardiomyopathy, aortic stenosis, 
abnormal serum values for potassium or total calcium, 
those treated with digitalis, diuretics, beta-blockers or 
other antihypertensive drugs, traumatic subarachnoid 
hemorrhage, hypertensive cerebral bleed and  brain 
tumours were excluded to avoid misinterpretation of 
ECG. 
Results 
       A total of 104 patients were screened in which 8 
were excluded from the study due to history of pre-
existing heart disease to avoid electrocardiographic, 
cardiac enzyme and echocardiographic abnormalities 
related to nonneurogenic mechanisms. Ultimately 96 
patients were included in the study. Among these 
57.6% were male and 39.4% were female. Mean age 
±SD was 45.9±22 with a range from 10 to 80 years. On 
presentation to the emergency department, pulse was 
77.2±13beats/min, systolic blood pressure 
126.7±18.3mmHg and diastolic blood pressure 
64.7±10.2 mmHg. Eleven patients (11.1%) developed 
pulmonary edema during ICU stay while 14.6% 
developed hypotension (Table 1). 
     ECG was abnormal in 75.7%. T wave inversion 
(35.5%) was the commonest. Echocardiography 
showed wall motion abnormalities in 17.2%. Ejection 
fraction was less than 50 in 12.1%.Cardiac troponin I 
was elevated in 15.6%(Table 2). 
Table 1:Subarachnoid haemorrhage-Clinical 
characteristics  
Clinical characteristics No(%) Mean±SD 
Age ± SD  45.9±22.2 
Male 57(57.6)  
Female 39(39.4)  
Pulse(beats/min)  77.2±13.6 
Systolic blood 
pressure(mmHg) 
 126.7±18.3 
Diastolic  blood 
pressure(mmHg) 
 64.9±10.2 
Pulmonary edema 11(11.1)  
Hypotension  14(14.6)  
 
Discussion 
     Patients with aneurysmal SAH manifest a spectrum 
of cardiac abnormalities which include haemodynamic 
derangements, electrocardiographic abnormalities and 
echocardiographic regional or global LV dysfunction. 
11,12 An abnormally prolonged QTc interval with large 
T waves is a common finding in patients with 
aneurysmal SAH.  Q-T interval , in the absence of 
conduction disturbances, is an indirect measure of the 
duration of cardiac repolarization. The prolongation 
may be due to a disturbed regional myocardial 
sympathetic activity, which may be part of a general 
disorder of the sympathetic nervous activity following 
aneurysmal SAH. The pattern of broad, slurred, 
inverted T waves associated with long QTc intervals is 
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commonly termed “cerebral,” “neurogenic,” or 
“giant” T wave. The U wave, which is often 1 mm or 
greater in amplitude in patients with SAH, can be 
mistakenly  
Table 2: Investigations in patients with 
subarachnoid haemorrhage 
Findings on Investigations No(%) 
ECG 
Abnormal ECG 75(75.8) 
Symmetrical T wave inversion 35(35.4) 
Hyperacute T wave 13(13.1) 
ST segment elevation 13(13.1) 
ST segment depression 32(32.2) 
Long QT  34(34.3) 
Prominent U wave 14(14.1) 
Sinus bradycardia 46(46.5) 
Sinus tachycardia 30(30.3) 
Right 
bundle branch block 
11(11.1) 
Long P-R interval 4(4.16) 
Junctional rhythm 3(3.12) 
AF 7(6.7) 
Ventricular premature beats 19(19.2) 
Atrial premature beats 33(33.3) 
Q -waves 13(13.1) 
Echocardiography 
Wall motion abnormality(WMA) 17(17.2) 
EF >50% 84(87.9) 
EF <50% 12(12.1) 
Cardiac Enzyme 
Troponin I 15(15.6) 
 
interpreted as part of a notched T wave if the U wave 
occurs early during repolarization. S-T segment 
depression is another ECG change often reported in 
SAH patients. ECG changes that occur during cardiac 
repolarization, such as abnormalities in the ST 
segment and the T wave, must be interpreted in the 
context of the patient’s neurological abnormalities. 
Neurologically mediated ECG changes are often 
misdiagnosed as myocardial ischemia or infarction, 
resulting in inadvertent or delayed treatment of the 
primary problem. 
     Theories about the underlying causes of ECG 
abnormalities in SAH are controversial. Cardiac injury 
due to elevated myocardial wall stress associated with 
tachycardia and hypertension has also been suggested 
as a causative factor. Coronary vasospasm and 
reversible post ischemic “stunned myocardium” may 
influence the development of ECG changes in patients 
with aneurysmal SAH. Evidence indicates a 
neurogenic etiology for ECG abnormalities in SAH. 
Animal studies suggest interesting links between brain 
structures and the heart. Unilateral alteration of 
sympathetic tone to the heart, is also partially held 
responsible. Injury to the insula, an area of the cortex 
thought to be involved in arrhythmogenesis, might be 
implicated in both abnormal cardiac rhythm and the 
focal myocardial lesions that sometimes occur after 
SAH. Currently, much research focuses on the release 
of catecholamines, either systemically or within the 
myocardium, as a cause of ECG abnormalities. The 
characteristic pattern of myocardial lesions suggested 
to some researchers that the damaging catecholamines 
are released from intramyocardial nerve endings 
rather than from the general circulation. Factors that 
may influence the development of arrhythmias in 
patients with SAH include cerebral vasospasm, 
hypoxia, electrolyte imbalance, and sudden increase in 
intracranial pressure triggering a sympathetic or vagal 
discharge due to compression of brain structures. The 
basic hemorrhagic nature of SAH may play a role in 
producing arrhythmias in the period immediately 
after hemorrhage.17-21 
     Some SAH patients do show evidence of structural 
cardiac damage. Plasma levels of creatine kinase 
myocardial isoenzyme (CK-MB) are mildly elevated in 
20% to 50% of patients. A characteristic form of 
myocardial pathology, contraction band necrosis, is 
commonly found at autopsy and has been produced in 
experimental SAH models.  
      Troponin I (cTnI) is a reliable marker of myocardial 
injury and poor prognosis in patients with unstable 
cardiac ischemia and also in patients with septic shock. 
An abnormal cTnI is a powerful predictor for the 
occurrence of pulmonary and cardiac complications in 
patients with aneurysmal SAH. The additional 
prognostic information of troponin I for poor outcome 
is limited. The severity of brain injury is the leading 
cause of a poor outcome and pulmonary and cardiac 
complications are less important factors for the 
eventual outcome. 22,24 
     Excessive catecholamine release after SAH is the 
driving force for left ventricular dysfunction of the 
heart and pulmonary edema. The severity of the brain 
injury is strongly related to the occurrence of these 
cardiac and pulmonary complications.Pathogenesis of 
neurogenic pulmonary edema is noncardiogenic, 
resulting primarily from injury to the pulmonary 
circulation. Neurogenic left ventricular dysfunction, in 
combination with noncardiogenic mechanisms, may 
contribute to the formation of pulmonary edema.25-27 
 
Conclusion 
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1.Neurologically mediated ECG changes are often 
misdiagnosed as myocardial ischemia or infarction, 
resulting in inadvertent or delayed treatment of the 
primary problem.  
2.Routine measurement of the length of the QTc 
interval in patients with SAH may help detect 
predisposition to potentially lethal tachyarrhythmias, 
particularly if the patient also has low serum levels of 
potassium. All these cardiac manifestations in 
aneurysmal SAH are transient and need supportive 
care. 
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